EN
抗体药类似物
Research Grade Grisnilimab
All
TD-HY302016_1.jpg
TD-HY302016_2.jpg
  • CatalogTD-HY302016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsWT1,CAS:2367001-70-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Grisnilimab


Catalog No. TD-HY302016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Mouse
Isotype IgG2a-Lambda
Expression system Mammalian Cells
Clonality Monoclonal
Target GP40, CD7, T-cell surface antigen Leu-9, T-cell leukemia antigen, TP41, T-cell antigen CD7
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P09564
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names WT1,CAS:2367001-70-3
Background Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY302016_1.jpg
Bioactivity
 
Detects Human CD7 in indirect ELISAs.
TD-HY302016_2.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Grisnilimab.